Cellot S, Hope KJ, Chagraoui J, Sauvageau M, Deneault E, Macrae T, Mayotte N, Wilhelm BT, Landry JR, Ting SB, Krosl J, Humphries K, Thompson A, Sauvageau G. (2013). RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity. Blood 122(9):1545-55. doi: 10.1182/blood-2013-04-496281
Deneault E, Wilhelm BT, Bergeron A, Barabé F, Sauvageau G. (2013). Identification of non-cell-autonomous networks from engineered feeder cells that enhance murine hematopoietic stem cell activity. Exp Hematol. 41(5):470-478.
Bisaillon R, Wilhelm BT, Krosl J, Sauvageau G. (2011). C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein. Blood 118, 4682-4689.
Chagraoui J, Hebert J, Girard S, Sauvageau G. (2011). An anticlastogenic function for the Polycomb Group gene Bmi1. PNAS 108(13):5284-9.
Wilhelm BT, Briau M, Austin P, Faubert A, Boucher G, Chagnon P, Hope K, Girard S, Mayotte N, Landry JR, Hebert J, Sauvageau G. (2011). RNA-seq Analysis of Two Closely Related Leukemia clones that Differ in their Self-Renewal Capacity. Blood 117,27-38.
Sauvageau M and Sauvageau G. (2010). Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer. Cell Stem Cell 7, 299-313.
Hope KJ, Cellot S, Ting SB, MacRae T, Mayotte N, Iscove NN, Sauvageau G. (2010). An RNAi Screen Identifies Msi2 and Prox1 as Having Opposite Roles in the Regulation of Hematopoietic Stem Cell Activity. Cell Stem Cell 7, 101-113.
Krosl J, Mamo A, Chagraoui J, Wilhelm BT, Girard S, Louis I, Lessard J, Perreault C, Sauvageau G. (2010). A mutant allele of the Swi/Snf member BAF250a determines the pool size of fetal liver hemopoietic stem cell population. Blood 116, 1678-1684.
Bilodeau M, MacRae T, Gaboury L, Laverdure JP, Hardy MP, Mayotte N, Paradis V, Harton S, Perreault C, Sauvageau G. (2009). Analysis of blood stem cell activity and cystatin gene expression in a mouse model presenting a chromosomal deletion encompassing Csta and Stfa2l1. PLoS One 4, e7500.
Sauvageau M, Miller M, Lemieux S, Lessard J, Hebert J, Sauvageau G. (2008). Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type specific cancer genes in leukemia. Blood 111, 790-9.
Sauvageau G, Perreault C. (2008). Killer granzyme B linked to N-myc- and c-myc-dependent HSC survival: isn't that comyc? Cell Stem Cell 3, 579-80.
Bijl J, Krosl J, Lebert-Ghali CE, Vacher J, Mayotte N, and Sauvageau G. (2008). Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia. Oncogene 27, 6356-64.
Cellot S, Krosl J, Chagraoui J, Meloche S, Humphries RK, and Sauvageau G. (2007). Sustained in vitro trigger of self-renewal divisions in Hoxb4hiPbx1(10) hematopoietic stem cells. Exp. Hematol. 35, 802-16.
Bilodeau M, Girard S, Hébert J, Sauvageau G. (2007). A retroviral strategy that efficiently creates chromosomal deletions in mammalian cells. Nat. Methods 4, 263-268.
Bilodeau M and Sauvageau G. (2006). Uncovering stemness. Nat. Cell Biol. 8, 1048-1049.
Krosl J, Beslu N, Mayotte N, Humphries RK, Sauvageau G. (2003). The competitive nature of HOXB4-transduced HSC is limited by PBX1: the generation of ultra-competitive stem cells retaining full differentiation potential. Immunity 18, 561-571.
Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G. (2003). In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat. Med. 9, 1428-1432.
Kroon E, Thorsteinsdottir U, Mayotte N, Nakamura T, Sauvageau G. (2001). NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. EMBO J. 20, 350-361.
Dr. Guy Sauvageau is named La Presse’s 2014 Personality of the Year in the Science category
Dr. Sauvageau’s team has made an unprecedented breakthrough with the discovery of a new molecule capable of multiplying the stem cells present in umbilical cord blood.
December 19, 2014
New publication for Dr. Sauvageau and his collegues from IRIC
SCL, LMO1 and Notch1 Reprogram Thymocytes into Self-Renewing Cells
October 19, 2014
Dr. Guy Sauvageau and his team have been nominated as «Personality of the Week» by the daily La Presse
It is for the discovery of a new molecule, the first of its kind, which allows for the multiplication of stem cells in a unit of cord blood. Umbilical cord stem cells are used for transplants aimed at curing a number of blood-related diseases, including leukemia, myeloma and lymphoma.